The immunomodulatory imide drug (a class of immunomodulatory drugs containing an imide group) includes thalidomide which has a protein binding of 5565% and has hydrolized metabolites.
Immunomodulatory imide drugs (IMiDs) are a class of immunomodulatory drugs (drugs that adjust immune responses) containing an imide group. The IMiD class includes thalidomide and its analogues (lenalidomide, pomalidomide, iberdomide, and apremilast). Main article: Thalidomide Protein binding 5565% Metabolites Hydrolized metabolites 
